Aurobindo Recalls Blood Pressure Tablets Contaminated With Nitrosamines

Aurobindo Pharma USA has recalled two lots of its combination quinapril 20mg/hydrochlorothiazide 12.5mg tablets for treatment of high blood because of nitrosamine contamination above the acceptable limit.

The affected batches were shipped to customers nationwide starting in May 2021.

The FDA has been investigating the presence of nitrosamine impurities in certain drug products since 2018. The nitrosamine compounds may increase the risk of cancer if people are exposed to them over long periods.

Aurobindo has not received any reports of adverse events related to the recall, according to the FDA.